Skip to main content

ORIGINAL RESEARCH article

Front. Bioeng. Biotechnol.
Sec. Biomaterials
Volume 12 - 2024 | doi: 10.3389/fbioe.2024.1512393
This article is part of the Research Topic Metallic Biomaterials for Medical Applications - Volume II View all articles

The degradation of WE43 Magnesium Alloy in vivo and its degradation Products on Macrophages

Provisionally accepted
li Dong li Dong 1Guangde Zhang Guangde Zhang 1*Zhiyuan Shen Zhiyuan Shen 1*Xiaojian Hong Xiaojian Hong 1*Yongli Xing Yongli Xing 2*Yue Wu Yue Wu 1*Wei Yang Wei Yang 1Binmei Zhang Binmei Zhang 1Zhiyu Shi Zhiyu Shi 3*
  • 1 The Fourth Hospital of Harbin Medical University, Harbin, China
  • 2 The Second Hospital of Harbin, Harbin, Jilin Province, China
  • 3 First Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang Province, China

The final, formatted version of the article will be published soon.

    Due to their biocompatibility, biodegradability, and suitable mechanical properties, magnesium-based biodegradable implants are emerging as a promising alternative to traditional metal implants. The Mg-4Y-3RE (WE43) biodegradable alloy is among the most extensively studied and widely utilized magnesium alloys in clinical applications. As an absorbable and degradable metallic material, magnesium alloys undergo gradual degradation, wear, and fracture within the body. These alloys reduce the long-term risks associated with permanent implants but generate insoluble byproducts that accumulate in surrounding tissues. Following the implantation of magnesium alloys, granulation tissue and fibrous encapsulation typically form around the material. However, limited research has addressed the interaction between insoluble byproducts of magnesium alloys and macrophages. This study focused on the biological effects of macrophages during the second stage of the host inflammatory response in the degradation process of magnesium alloy. Using subcutaneous implantation of WE43 magnesium alloy sheets, observations were made regarding the degradation components, morphological changes in surrounding tissues, and the biological effects of macrophages upon phagocytosis of insoluble byproducts. The primary degradation products of WE43 in vivo were identified as Ca3(PO4)2, Mg3(PO4)2, Na3PO4, NaCa(PO4), MgSO4, MgCO3, NaCl, Mg24Y5, and Mg12YNd. Post-implantation, levels of IL-1β and IL-18 in adjacent tissues significantly increased (p<0.05). By 8 weeks, compared to nitinol alloy, significant thickening of the fibrous capsule (p<0.05) was observed, accompanied by substantial inflammatory cell infiltration, vascularization, and the presence of macrophages and multinucleated giant cells. Macrophages were observed extending pseudopodia to enclose and phagocytose particles, forming phagosomes and creating a relatively isolated microenvironment around the engulfed substances, where further particle degradation occurred. Following the phagocytosis of degradation products, macrophages exhibited increased lysosome numbers, mitochondrial swelling and damage, phagolysosome formation, and autophagosome development. Furthermore, the degradation products were observed to induce elevated reactive oxygen species (ROS) production in macrophages, activation of P2X7 receptors, enhanced IL-6 secretion, endoplasmic reticulum stress, autophagy, and activation of the NLRP3 inflammasome pathway. This study provides novel insights and contributes a theoretical foundation for a more comprehensive understanding of magnesium alloy degradation in vivo.

    Keywords: WE43, Degradation products, Macrophages, Inflammation, reactive

    Received: 16 Oct 2024; Accepted: 24 Dec 2024.

    Copyright: © 2024 Dong, Zhang, Shen, Hong, Xing, Wu, Yang, Zhang and Shi. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

    * Correspondence:
    Guangde Zhang, The Fourth Hospital of Harbin Medical University, Harbin, China
    Zhiyuan Shen, The Fourth Hospital of Harbin Medical University, Harbin, China
    Xiaojian Hong, The Fourth Hospital of Harbin Medical University, Harbin, China
    Yongli Xing, The Second Hospital of Harbin, Harbin, Jilin Province, China
    Yue Wu, The Fourth Hospital of Harbin Medical University, Harbin, China
    Zhiyu Shi, First Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang Province, China

    Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.